Clinical Trial Update: Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents [Phase 2]

View source ↗

Summary

Phase 2 study evaluating lurasidone in antipsychotic-naive or quasi-naive children and adolescents with schizophrenia-spectrum and mood disorders; results were …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Bipolar Disorder
• Bipolar Ii Disorder
• Major Depressive Disorder
• Mood Disorder Nos
• Schizoaffective Disorder
• Schizophrenia
• Schizophreniform Disorder

Drugs mentioned

• Latuda (lurasidone)

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 2 | Status: COMPLETED | Results posted: 2017-05-17